MedTrace Logo

How to Reduce Pain in Patients Undergoing Office Hysteroscopy.

NCT05911126 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-06-20

No results posted yet for this study

Summary

The aim of this study is to compare the effectiveness and the side effects of hyosine-N- butylbromide (HBB) \& Celecoxib administered alone versus in combination reducing pain associated with outpatient hysteroscopy in married female patients aged 18-40 attending the outpatient hysteroscopy clinic of Kasr Al Ainy, Cairo University Hospital.

Conditions

Interventions

DRUG

Celecoxib 200 mg, Hyoscine-N-butyl bromide (HBB), placebo tablet

Tablet form received prior to the procedure

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Eman A Hussein, MD · Cairo University

  • Nihal M El-Demiry, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-13
Primary Completion
2023-10-13
Completion
2023-12-13

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05911126 on ClinicalTrials.gov